Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV multicenter trial of Shaoma Zhijing Granules in children with tic disorders
CTR20211946Phase 4Active
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Feb 2022
- Countries
- 1
01
Overview
A Phase 4 trial of Shaoma Zhijing granule in Tourette syndrome (TS), chronic tic disorder, sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Feb 2022; status: active.
02
Drugs
Shaoma Zhijing granule
03
Conditions
Tourette syndrome (TS)chronic tic disorder
Beyond the preview
Go deeper on CTR20211946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211946.